
PTC Therapeutics, Inc.
PTCTNasdaqCIK 1070081HealthcareFiscal year ends Dec 31
Reports and events: 261 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2616:30 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001558370-24-005924 |
| 2024-04-2516:36 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-005782 |
| 2024-04-2516:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-005767 |
| 2024-02-2916:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002196 |
| 2024-02-2916:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-002189 |
| 2024-01-2516:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000006 |
| 2024-01-0809:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000003 |
| 2023-10-2616:34 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001070081-23-000065 |
| 2023-10-2616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000063 |
| 2023-10-1916:15 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001070081-23-000059 |
| 2023-10-1908:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001070081-23-000056 |
| 2023-09-2816:45 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000053 |
| 2023-09-2209:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-103032 |
| 2023-09-1506:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-015770 |
| 2023-08-0316:34 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001070081-23-000050 |
| 2023-08-0316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000048 |
| 2023-07-1912:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001070081-23-000043 |
| 2023-07-1716:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001070081-23-000040 |
| 2023-06-2107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000036 |
| 2023-06-1516:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-071641 |
| 2023-06-0616:04 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001070081-23-000033 |
| 2023-05-2317:17 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-063688 |
| 2023-05-1707:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001070081-23-000030 |
| 2023-04-2716:35 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001070081-23-000028 |
| 2023-04-2716:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000026 |
| 2023-04-2608:22 ET | DEF 14A | Proxy statement | 0001070081-23-000020 |
| 2023-04-1817:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001070081-23-000015 |
| 2023-03-2407:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-036263 |
| 2023-03-0816:16 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001104659-23-030113 |
| 2023-02-2116:50 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001070081-23-000011 |
| 2023-02-2116:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000008 |
| 2023-01-0909:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-23-000004 |
| 2022-12-0616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-124889 |
| 2022-10-2716:38 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001070081-22-000041 |
| 2022-10-2716:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-22-000038 |
| 2022-10-2716:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-112002 |
| 2022-10-1816:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-22-000035 |
| 2022-09-0707:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-014219 |
| 2022-08-1517:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-013641 |
| 2022-08-0416:35 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001070081-22-000031 |
| 2022-08-0416:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-22-000029 |
| 2022-06-2108:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-010112 |
| 2022-06-0909:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-009860 |
| 2022-05-2716:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001070081-22-000020 |
| 2022-05-0316:36 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001070081-22-000017 |
| 2022-05-0316:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-22-000015 |
| 2022-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2022-06-08 | 0001558370-22-006288 |
| 2022-02-2216:36 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001070081-22-000011 |
| 2022-02-2216:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-22-000009 |
| 2022-01-1007:21 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-000153 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 17:24 ET. Listed shows no prices and gives no investment advice.